NCT00041418

Brief Summary

To use magnetic resonance imaging to identify subclinical atherosclerosis and left ventricular hypertrophy in the Framingham Heart Study cohort.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Sep 2001

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2001

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 8, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 9, 2002

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2006

Completed
Last Updated

July 29, 2016

Status Verified

January 1, 2008

Enrollment Period

4.9 years

First QC Date

July 8, 2002

Last Update Submit

July 28, 2016

Conditions

AtherosclerosisHeart DiseasesCardiovascular DiseasesHypertrophy, Left Ventricular

Eligibility Criteria

AgeUp to 100 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Members of the Framingham Heart Study include the cohort first examined beginning in 1948, their offspring and spouses first examined between 1971 and 1975, and a minority population, the Omni cohort.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (1)

  • Neisius U, Gona PN, Oyama-Manabe N, Chuang ML, O'Donnell CJ, Manning WJ, Tsao CW. Relation of MRI Aortic Wall Area and Plaque to Incident Cardiovascular Events: The Framingham Heart Study. Radiology. 2022 Sep;304(3):542-550. doi: 10.1148/radiol.210830. Epub 2022 May 31.

    PMID: 35638924DERIVED

MeSH Terms

Conditions

AtherosclerosisHeart DiseasesCardiovascular DiseasesHypertrophy, Left Ventricular

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiomegalyHypertrophyPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Warren Manning

    Beth Israel Deaconess Medical Center

Study Design

Study Type
observational
Sponsor Type
NIH

Study Record Dates

First Submitted

July 8, 2002

First Posted

July 9, 2002

Study Start

September 1, 2001

Primary Completion

August 1, 2006

Study Completion

August 1, 2006

Last Updated

July 29, 2016

Record last verified: 2008-01